Viridian Therapeutics, Inc.\DE (VRDN) Return on Capital Employed Growth (5y) (2019 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,063.00 |
| Dec 31, 2025 | 10,022.00 |
| Sep 30, 2025 | 13,988.00 |
| Jun 30, 2025 | 16,134.00 |
| Mar 31, 2025 | 22,775.00 |
| Sep 30, 2024 | 17,939.00 |
| Jun 30, 2024 | 7,787.00 |
| Mar 31, 2024 | 3,036.00 |
| Dec 31, 2023 | -1,524.00 |
| Sep 30, 2023 | -3,319.00 |
| Jun 30, 2023 | -2,978.00 |
| Mar 31, 2023 | -1,053.00 |
| Dec 31, 2022 | 2,462.00 |
| Sep 30, 2022 | 2,126.00 |
| Jun 30, 2022 | -1,225.00 |
| Mar 31, 2022 | 1,131.00 |
| Dec 31, 2021 | 14,324.00 |
| Sep 30, 2021 | 16,706.00 |
| Jun 30, 2021 | 5,078.00 |
| Mar 31, 2021 | 1,951.00 |